- Home
- WAI vs BRTX Comparison
WAI vs BRTX Comparison
Compare WAI & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- BRTX
- Stock Information
- Founded
- WAI 2018
- BRTX 1997
- Country
- WAI China
- BRTX United States
- Employees
- WAI N/A
- BRTX N/A
- Industry
- WAI
- BRTX Managed Health Care
- Sector
- WAI
- BRTX Health Care
- Exchange
- WAI NYSE
- BRTX Nasdaq
- Market Cap
- WAI 14.8M
- BRTX 12.6M
- IPO Year
- WAI 2023
- BRTX N/A
- Fundamental
- Price
- WAI $3.44
- BRTX $1.61
- Analyst Decision
- WAI
- BRTX Strong Buy
- Analyst Count
- WAI 0
- BRTX 1
- Target Price
- WAI N/A
- BRTX $18.00
- AVG Volume (30 Days)
- WAI 673.2K
- BRTX 253.7K
- Earning Date
- WAI 08-24-2025
- BRTX 08-12-2025
- Dividend Yield
- WAI N/A
- BRTX N/A
- EPS Growth
- WAI N/A
- BRTX N/A
- EPS
- WAI N/A
- BRTX N/A
- Revenue
- WAI $3,750,352.00
- BRTX $391,000.00
- Revenue This Year
- WAI N/A
- BRTX $391.52
- Revenue Next Year
- WAI N/A
- BRTX $3.50
- P/E Ratio
- WAI N/A
- BRTX N/A
- Revenue Growth
- WAI N/A
- BRTX 161.54
- 52 Week Low
- WAI $1.38
- BRTX $1.21
- 52 Week High
- WAI $20.00
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- BRTX 46.78
- Support Level
- WAI N/A
- BRTX $1.57
- Resistance Level
- WAI N/A
- BRTX $1.72
- Average True Range (ATR)
- WAI 0.00
- BRTX 0.13
- MACD
- WAI 0.00
- BRTX -0.01
- Stochastic Oscillator
- WAI 0.00
- BRTX 20.65
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.